Quantcast

Latest Nilotinib Stories

2006-06-28 17:19:35

WASHINGTON (Reuters) - A new Bristol-Myers Squibb Co. pill won U.S. approval for fighting two types of leukemia in patients running out of treatment options, the company said on Wednesday. The drug called Sprycel was shown to help some patients with chronic myeloid leukemia (CML) that had stopped responding to Novartis AG's pill Gleevec. Bristol-Myers said it expects to have the drug on the market within days. In addition to CML, the FDA approval covers treatment of adults with...

2006-06-15 05:20:00

By Gene Emery BOSTON -- Two new drugs may help treat some adult cases of leukemia that fail to respond to Novartis AG's Gleevec, two studies showed on Wednesday. One drug, dasatinib, an experimental Bristol-Myers Squibb drug recently endorsed by a Food & Drug Administration advisory panel, could receive full approval by the end of June. Dasatinib helped 68 out of 84 volunteers suffering from a form of chronic myeloid leukemia, or CML, that was resistant to Novartis's Gleevec, according...

2006-06-14 16:17:58

By Gene Emery BOSTON (Reuters) - Two new drugs may help treat some adult cases of leukemia that fail to respond to Novartis AG's Gleevec, two studies showed on Wednesday. One drug, dasatinib, an experimental Bristol-Myers Squibb Co. drug recently endorsed by a Food & Drug Administration advisory panel, could receive full approval by the end of June. Dasatinib helped 68 out of 84 volunteers suffering from a form of chronic myeloid leukemia, or CML, that was resistant to...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related